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Abstract. The hemostatic system is a highly complex multicomponent biosys-
tem that under normal physiologic conditions maintains the fluidity of blood.
Coagulation is initiated in response to endothelial surface vascular injury or
certain biochemical stimuli, by the exposure of plasma to Tissue Factor (TF),
that activates platelets and the coagulation cascade, inducing clot formation,
growth and lysis. In recent years considerable advances have contributed to
understand this highly complex process and some mathematical and numerical
models have been developed. However, mathematical models that are both
rigorous and comprehensive in terms of meaningful experimental data, are not
available yet. In this paper a mathematical model of coagulation and fibrinol-
ysis in flowing blood that integrates biochemical, physiologic and rheological
factors, is revisited. Three-dimensional numerical simulations are performed
in an idealized stenosed blood vessel where clot formation and growth are ini-
tialized through appropriate boundary conditions on a prescribed region of
the vessel wall. Stability results are obtained for a simplified version of the
clot model in quiescent plasma, involving some of the most relevant enzymatic
reactions that follow Michaelis-Menten kinetics, and having a continuum of
equilibria.
1. Introduction. When a blood vessel is injured, a complex physiologic process
characterized by interactions between the vessel wall, platelets, coagulation factors
and their inhibitors and fibrinolytic proteins, is set into action. This process, called
hemostasis, leads to the formation of a solid fibrin clot to cover the vascular lesion
and to stop hemorrhage. It includes several steps: (1) vasoconstriction, to reduce
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blood input and loss in the damaged region; (2) primary hemostasis, induced by
platelets activation in contact with collagen exposed by arterial damage, resulting in
the formation of a hemostatic plug within seconds after the injury. Platelets can also
be activated and form aggregates by prolonged exposure to sharp or rapid increases
in shear stress [8]; (3) secondary hemostasis or coagulation, a complex cascade
of enzymatic reactions involving coagulation factors, down to the production of
Thrombin which converts Fibrinogen into Fibrin, stabilizing the platelet plugs and
forming a blood clot (or thrombus). It has two pathways, intrinsic and extrinsic,
which join in a common pathway leading to Fibrin production; (4) wall repair:
the clot attracts and stimulates the growth of fibroblasts and smooth muscle cells,
repairing the vessel wall; (5) clot dissolution (or clot lysis), leading to the restoration
of normal blood flow conditions, at the end of the hemostatic process.
Blood clots are continuously produced and dissolved inside blood vessels. How-
ever, some abnormal hemodynamic and biochemical conditions can lead to severe
pathologies such as bleeding or thromboembolic disorders. In the last case, clots
can detach to form an embolus which can lodge in a smaller vessel downstream
from the site of thrombosis, induce ischemia of the irrigated tissues, and result in a
stroke, heart attack or pulmonary embolism.
The process of blood clotting produced by the mechanical activation of platelets
combined with a biochemical cascade of kinetic reactions, is quite complex and
not yet well understood. Experimental studies recognize that clot formation and
growth primarily occur in stagnation flow regions, within blood vessel bifurcations,
branching, strong curvatures or severe stenoses. Moreover, internal cardiovascular
devices such as prosthetic heart valves, ventricular assist devices and stents, gener-
ally harbor high hemodynamic shear stresses that can cause platelet activation and
result in clot formation. Thrombotic deposition is a major cause of failure of those
medical devices.
In recent years considerable advances have contributed to understand this highly
complex process. Reviews describing the blood coagulation system are available
(see, e.g. [1], [14]) but comprehensive mathematical models have been lacking in
general. Most models have focused only on biochemical systems, others incorporate
some fluid mechanical factors but not the mechanical properties of blood and the
forming clots [3], [9], [16]. Moreover, these models rely on experimental data ob-
tained from reductionist in vitro experiments and with little physiological relevance.
Anand et al. [1] recently developed a mathematical model for clot formation and
lysis in flowing blood that attempts to extend existing models, to integrate more
of the biochemical, physiologic and rheological factors, but it is yet far from being
complete. Preliminary 3D numerical results for a simplified version of this model,
where the viscoelasticity of blood is not considered, can be found in [5].
Numerical simulations motivated the need to better understand the behavior of
this mathematical model. In particular, problems of chemical stability and equi-
libria have gained high importance. From the physiological point of view, clot
formation generally occurs due to specific perturbations in the hemostatic system.
However, under normal, undisturbed conditions, biochemical constituents of blood
are in a kind of chemical equilibrium and thus no coagulation processes take place.
Normal concentrations of the biochemical species seem also to be equilibrium so-
lutions of the coagulation system, in the sense that, if they are slightly perturbed,
they tend to revert back to their equilibrium (normal) values. Therefore, in view
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of these considerations, the stability analysis of the biochemical system becomes
mandatory.
This paper is mainly devoted to the study of stability of equilibria of some of the
most relevant enzymatic reactions involved in the biochemical part of the model
analyzed in [5]. It is organized as follows. The coupled problem is formulated
in Sect. 2 and results of the 3D numerical simulations performed in an idealized
stenosed vessel are presented in Sect. 3. Finally, preliminary stability results can
be found in Sect. 4 and the paper ends with some concluding remarks.
2. Formulation of the mathematical model. We briefly recall the coupled
blood flow - biochemistry model of clot growth and lysis studied in [5].
It is assumed that the flow of blood is governed by the equations for an incom-
pressible generalized Newtonian fluid with shear-thinning viscosity
ρ
(
∂u
∂t
+ u · ∇u
)
= −∇p+ div τ(u)
div u = 0
(1)
completed with appropriate initial and boundary conditions. In these equations,
defined in a three-dimensional domain Ω, u(x, t) is the velocity field, p(x, t) is the
pressure, ρ is the fluid density and τ(u) is the deviatoric stress tensor. This tensor
defined by
τ(u) = 2µ(γ˙)D (2)
and is proportional to the symmetric part of the velocity gradient D = (∇u +
∇uT )/2, γ˙ = 2√D : D is the shear rate (a measure of the rate of shear deformation)
and µ(γ˙) is the shear dependent viscosity function inversely related to the shear rate.
Here, we consider the generalized Cross model to account for the shear-thinning
behavior of blood. The corresponding viscosity function is written as
µ(γ˙)− µ∞
µ0 − µ∞ =
1
(1 + (λγ˙)b)
a (3)
where µ0 and µ∞ are the asymptotic viscosities at low and high shear rates and
parameters λ, a and b are estimated by curve fitting of experimental data (see [13]).
In particular we take µ0 = 1.6 · 10−1Pa · s, µ∞ = 3.6 · 10−3Pa · s, a = 1.23, b = 0.64
and λ = 8.2s, from [10].
To simulate the cascade of biochemical reactions involved in the coagulation
process, a system of 23 coupled advection-diffusion-reaction equations is used. It
describes the evolution in time and space of various enzymes and zymogenes, pro-
teins, inhibitors, Tissue Plasminogen Activator and Fibrin/Fibrinogen (see Table
1) leading to the formation, growth and dissolution of clots in quiescent plasma. It
is based on the model introduced in [1] and further developed in [2] (see also [5]),
as already mentioned.
This system takes the form
∂[Ci]
∂t
+ div ([Ci] u) = div (Di∇[Ci]) + Ri i = 1, . . . , 23 (4)
where [Ci] represents the concentration of the i−th constituent, Di denotes the
diffusion coefficient associated with Ci and u is the velocity field. The nonlinear
reaction terms that represent the production or depletion of Ci due to the enzymatic
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cascade of reactions are represented by Ri and their specific form is shown in Table
2, which also contains the diffusion coefficients, obtained from experiments, (see
[1], [2] and references cited therein). Some of the reactions follow Michaelis-Menten
kinetics and others follow first order or second order kinetics.
Species Names Species Names
IXa Factor IXa XIa Factor XIa
IX Factor IX XI Factor XI
V IIIa Factor VIIIa ATIII AntiThrombin-III
V III Factor VIII TFPI Tissue Factor Pathway Inhibitor
V a Factor Va APC Active Protein C
V Factor V PC Protein C
Xa Factor Xa L1AT α1-AntiTrypsin
X Factor X tPA Tissue Plasminogen Activator
IIa Thrombin PLA Plasmin
II Prothrombin PLS Plasminogen
Ia Fibrin L2AP α2-AntiPlasmin
I Fibrinogen Z Tenase
W Prothrombinase
Table 1. Constituents involved in the coagulation cascade and
fibrinolysis
Equations (4) are complemented with appropriate initial and flux boundary con-
ditions involving the concentration of various species at an injured site of the vas-
cular wall.
Initially there is no clot. Coagulation starts by the exposure of blood to Tissue
Factor (TF-VIIa complex), released from sub-endothelium in an injured region of
the vessel wall. Tissue Factor binds Factor VIIa and activates factors IX and X.
Once Factor Xa is generated, the coagulation process develops and a clot is formed
when Fibrin concentration [Ia] is equal or greater than a specific value in certain
flow region located at the vicinity of the injured wall. When [Ia] drops below this
value or a high shear stress forces clot’s rupture, the repair process of the injury
begins, resulting in fibrinolysis and clot dissolution.
We assume the same constitutive model for the blood and the clot, but we impose
different viscosity values. A viscosity factor related to the Fibrin concentration
around the injured vessel wall region is introduced such that, it is equal to 1 when
Fibrin concentration is close to zero and the local viscosity is equal to the viscosity
of blood. As the Fibrin concentration grows, the viscosity increases linearly up to a
certain threshold CClot and the viscosity factor is equal to µ
∗. The parameters µ∗
and Cclot should be chosen to mimic the clot properties. In our study we have used
µ∗ = 100 and CClot = 1000 nM corresponding to a viscosity of the clot region 100
times higher than that of the blood.
This empirical assumption based on a Fibrin concentration viscosity factor makes
reasonable predictions but should be improved if additional constituents and their
interactions are incorporated in the biochemical model.
3. Numerical simulations and results. The governing equations for the cou-
pled blood-biochemistry model (1) - (4) have been solved using a finite volume
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Species Reaction Terms Diffusion Coeff.
[cm2/s]
IXa k9[XIa][IX]K9M+[IX] − h9[IXa][ATIII] 6.27× 10−7
IX − k9[XIa][IX]K9M+[IX] 5.63× 10−7
V IIIa k8[IIa][V III]K8M+[V III] − h8[V IIIa]−
hC8[APC][V IIIa]
HC8+[V IIIa]
3.92× 10−7
V III − k8[IIa][V III]K8M+[V III] 3.12× 10−7
V a k5[IIa][V ]K5M+[V ] − h5[V a]−
hC5[APC][V a]
HC5M+[V a]
3.82× 10−7
V − k5[IIa][V ]K5M+[V ] 5.63× 10−7
Xa k10[Z][X]K10M+[X] − h10[Xa][ATIII]− hTFPI [TFPI][Xa] 7.37× 10−7
X − k10[Z][X]K10M+[X] 5.63× 10−7
IIa k2[W ][II]K2M+[II] − h2[IIa][ATIII] 6.47× 10−7
II − k2[W ][II]K2M+[II] 5.21× 10−7
Ia k1[IIa][I]K1M+[I] −
h1[PLA][Ia]
H1M+[Ia]
2.47× 10−7
I − k1[IIa][I]K1M+[I] 3.10× 10−7
XIa k11[IIa][XI]K11M+[XI] − hA311 [XIa][ATIII]− hL111 [XIa][L1AT ] 5.00× 10−7
XI − k11[IIa][XI]K11M+[XI] 3.97× 10−7
ATIII −(h9[IXa] + h10[Xa] + h2[IIa] + hA311 [XIa])[ATIII] 5.57× 10−7
TFPI −hTFPI [TFPI][Xa] 6.30× 10−7
APC kPC [IIa][PC]KPCM+[PC] − hPC [APC][L1AT ] 5.50× 10−7
PC − kPC [IIa][PC]KPCM+[PC] 5.44× 10−7
L1AT −hPC [APC][L1AT ]− hL111 [XIa][L1AT ] 5.82× 10−7
tPA 0 5.28× 10−7
PLA kPLA[tPA][PLS]KPLAM+[PLS] − hPLA[PLA][L2AP ] 4.93× 10−7
PLS − kPLA[tPA][PLS]KPLAM+[PLS] 4.81× 10−7
L2AP −hPLA[PLA][L2AP ] 5.25× 10−7
Z [Z] = [V IIIa][IXa]KdZ 0.0
∗
W [W ] = [V a][Xa]KdW 0.0
∗
Table 2. Reaction terms and diffusion coefficients
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space-discretization on structured grids, and an explicit multistage Runge-Kutta
time integration scheme. To avoid numerical oscillations a pressure stabilization
technique has been implemented. We look for steady solutions by a time-marching
approach, i.e. the unsteady governing systems are solved with steady boundary con-
ditions and stationary solutions are recovered when t tends to infinity. At each time
step an iterative process is used to couple the flow and the biochemical solutions.
First, the velocity field is computed using equations (1) with a given viscosity, and is
inserted into (4) to obtain the concentrations (including that of Fibrin). Next, the
local viscosity is updated by a factor which depends on the calculated Fibrin con-
centration in the clotting area (as described above), and the flow field is recomputed
in the next time step using the updated viscosity (see [5] for further details).
Numerical simulations have been performed in an idealized non-symmetric (with
respect to the bulk flow direction) cosine-shaped stenosed vessel. The vessel is
assumed to be three-dimensional, axisymmetric, rigid-walled, with circular cross-
section, and with length L = 10R = 31mm and diameter D = 2R = 6.2mm (see
Fig. 1 (a)). The diameter is reduced to one half in the stenosed region, which leads
to a 4 : 1 cross-sectional area reduction and thus to a significant speed-up of the
local flow.
A parabolic velocity profile is prescribed at the inlet, with flow rateQ = 2 cm3s−1,
while at the outlet flow is assumed to be fully developed, i.e. homogeneous Neu-
mann conditions are imposed for the velocity components and the pressure is
fixed to a constant. On the vessel walls no-slip Dirichlet conditions are used
for the velocity field. Moreover, homogeneous Neumann boundary conditions for
the concentrations of all the chemical species are imposed at the healthy ves-
sel wall. To simulate the wall injury, non-homogeneous Neumann conditions for
seven selected species, directly involved in the initiation of the coagulation cascade
(IXa, IX,Xa,X,XIa,XI, tPa), are imposed in that region [5].
R 2R
R2R 2R 5R
10R
(a) stenosis
X
Y
Z
(b) vessel wall initial injury
Figure 1. Computational domain
Physiological values have been used as initial conditions for the concentrations
of the biochemical species. These values can be found in the literature, except
those of the activated species [1], [2]. Theoretically, the lowest values could initially
be considered equal to zero. However, to avoid numerical instabilities, we were
compelled to take non zero values and considered a 0.1% initial activation. The
initial conditions actually used are listed in Table 3, (see also [1], [2] and [5]).
The computational domain was discretized using a structured, wall fitted mesh
with hexahedral cells. To avoid high distortion of cells, a multiblock mesh structure
was adopted, with an outer mesh block of 64× 16× 1100 cells and a central mesh
block of 16× 16× 110 control volumes.
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Species Initial values [nM ] Species Initial values [nM ]
IXa 0.09 XIa 0.03
IX 90.0 XI 30.0
V IIIa 0.0007 ATIII 2410.0
V III 0.7 TFPI 2.5
V a 0.02 APC 0.06
V 20.0 PC 60.0
Xa 0.17 L1AT 45000.0
X 170.0 tPA 0.08
IIa 1.4 PLA 2.18
II 1400.0 PLS 2180.0
Ia 7.0 L2AP 105.0
I 7000.0
Table 3. Initial concentrations
The center of the simulated clotting area was placed at the wall vessel, 4R from
the inlet. The clotting surface was considered inside a sphere of diameter R. The
location of the wall injury was chosen in a region of stagnant or recirculation flow,
downstream the stenosis, where thrombosis can occur (see Fig. 1 (b)).
The concentrations of all chemical species involved in the model have been com-
puted pointwise in the whole computational domain. Figure 2 illustrates the evo-
lution in time (600s) of the concentrations of some of the most important species
in the center of the clotting surface. In particular, we observe a jump in all these
concentrations, approximately 100s after the initiation of the clotting cascade and
a rapid increase of Fibrin concentration, with a maximum value attained approxi-
mately at 150s, remaining relatively stable after that time. Moreover, results shown
in Fig. 2 also suggest that in the clotting process, ATIII deficiency is more relevant
than PC deficiency, as observed in [1], in a similar situation.
Cloth growth on the vessel wall after 600 seconds, based on the significant increase
of Fibrin concentration in the clotting area, is shown in Fig. 3. The blood flow
direction is from left to right. Due to advection Fibrin is transported downstream
the injured vessel wall region and during the clotting process the shape of the clot is
changed. In these simulations we could also observe the first steps of clot dissolution,
in regions where Fibrin concentration starts to decrease.
Figure 4 shows flow deceleration caused by the increase of Fibrin concentration.
Flow velocity reduces in the clot area due to the enhancement of local viscosity.
The blue region indicates low flow speed, while red areas correspond to high speed
undisturbed flow.
It is natural to assume that concentrations of chemicals transported by blood do
not vary in time. This state could be called a chemical equilibrium and equilibria
concentrations, or some close values, could be used as initial conditions. (Note that
values close to those in Table 3 give results similar to the ones shown in Fig. 2). This
and what was referred earlier concerning the 0.1% initial activation, motivated the
need for studying the stability of the system, which is done in a particular setting,
in Sect. 4.2.
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Figure 2. Time evolution of selected concentrations in the center
of clotting surface.
A related issue is the fact that reaction terms representing second order or
Michaelis-Menten approximations will be equal to zero unless both species involved
have non vanishing concentrations. Therefore, if one concentration is perturbed on
the boundary and the other (activated) is initiated to zero the process of coagu-
lation will not be able to start. In Sect. 4.1 we establish a result relating kinetic
equations and Michaelis-Menten approximations, which also shows how initial data
to the two systems relate to each other. Since the full problem is a (coupled) mul-
tiscale problem, this is also a way to understand the relationship between initial
values of activated and non activated species.
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Figure 3. Fibrin concentration on the vessel surface after 600 seconds
X
Y
Z
w: 1.00E-06 1.51E-05 2.93E-05 4.34E-05 5.76E-05 7.17E-05 8.59E-05 1.00E-04
Figure 4. Axial velocity in the near-wall layer after 600 seconds
4. Stability of the coagulation model in quiescent plasma.
4.1. Equations governing the biochemical cascade. The coagulation cascade
described by equations (4) include several chemical reactions that are assumed to
follow first order, second order and Michaelis-Menten kinetics. We briefly recall
how Michaelis-Menten approximations are obtained from a set of kinetic equations
[11].
Consider a chemical reaction
S + E
k1

k−1
C
k2−→ E + P,
where a substrate S reacts with an enzyme E. The result of this reaction is, ir-
reversibly, a product P and the enzyme E. Meanwhile, reversibly, a complex C
is formed. By mass action laws we know that concentrations are solutions of the
434 ADE´LIA SEQUEIRA, RAFAEL F. SANTOS AND TOMA´Sˇ BODNA´R
following system of ordinary differential equations:
d
dt
[S] = −k1 [S] [E] + k−1 [C], (5)
d
dt
[E] = −k1 [S] [E] + (k−1 + k2) [C], (6)
d
dt
[C] = k1 [S] [E]− (k−1 + k2) [C], (7)
d
dt
[P ] = k2 [C], (8)
along with the initial conditions
[S](0) = [S0], [E](0) = [E0], [C](0) = [C0], [P ](0) = [P0],
where [X] denotes the concentration of X, and k1, k−1 and k2 are rate constants for
the association of the substrate S and the enzyme E, the dissociation of (unaltered)
substrate from the enzyme and the dissociation of the product from the enzyme,
respectively.
By adding equations (6) and (7) it follows that E(t) +C(t) is a constant in time,
that is E(t)+C(t) = E0. This allows to reduce system (5)-(8) to the system formed
by equation (8) and
d
dt
[S] = −k1 [S] ([E0]− [C]) + k−1 [C], (9)
d
dt
[C] = k1 [S] ([E0]− [C])− (k−1 + k2) [C]. (10)
We now make the so called quasi-steady-state assumption: the rate of the overall
reaction, that is, the rate of formation of the product, ddt [P ], is almost constant.
Therefore C is also “almost constant”, from which it follows that ddt [C] ≈ 0.
Defining the Michaelis-Menten constant, KM , by KM =
k−1+k2
k1
, the quasi-
steady-state assumption implies
[C] ≈ [E0] [S]
KM + [S]
. (11)
Going back to equation (9), we find that
d[S]
dt
≈ −k2 [E0] [S]
KM + [S]
. (12)
which is the well known Michaelis-Menten approximation.
Observe now that the product reaction rate can be obtained as
d
dt
[P ] ≈ k2 [E0] [S]
KM + [S]
.
Remark 1. If E is continuously supplied in time, then
d[S]
dt
≈ − k2 [E] [S]
KM + [S]
,
d
dt
[P ] ≈ k2 [E] [S]
KM + [S]
,
which is the form encountered in the reaction terms of system (4).
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We now recall, following [15], how Michaelis-Menten approximation can be ob-
tained as the solution to a singular perturbation problem. We first introduce the
following scaled dimensionless variables
s = [S]/[S0]; c = [C]/
[E0][S0]
KM + [S0]
; T = t/
k2 [E0]
KM + [S0]
;
and also define the parameters
σ = [S0]/KM ; k = k−1/k2;  =
[E0]
KM + [E0]
,
with 0 <  << 1 (see e.g. [5]).
The dimensionless form of equations (9)-(10) is then given by
ds
dT
= (k + 1)(σ + 1)
[
−s + σ
σ + 1
cs +
k(k + 1)−1
σ + 1
c
]
, (13)

dc
dT
= (k + 1)(σ + 1)
[
s − σ
σ + 1
cs − 1
σ + 1
c
]
. (14)
Problem (13)-(14) is a singular perturbation problem. The solution of a singular
perturbation problem of this type consists in general, of two parts: one initial layer,
whose size decreases exponentially with time and an interior solution “in the large”,
that is, after the dying out of the initial layer part of the solution. Here, we are
interested in the interior solution. It is sought in the form
s(T ) = s0(T ) + s1(T ) + 
2s2(T ) + · · · , (15)
c(T ) = c0(T ) + c1(T ) + 
2c2(T ) + · · · . (16)
Inserting (15) and (16) into (13) and (14) and equating like powers of , we find,
at order zero, that c0 and s0 should verify
c0(T ) =
(σ + 1)s0(T )
σs0(T ) + 1
, (17)
ds0
dT
(T ) = − (σ + 1)s0(T )
σs0(T ) + 1
, (18)
the last equation being the dimensionless form of equation (12). Note that, in the
reaction terms of the blood coagulation system (4) (see Table 2) only the approxi-
mations of order zero appear, that is, in dimensionless form, s0 and c0. As usual,
f = O() if there exists a positive constant C such that |f | ≤ C. We have the
following theorem:
Theorem 4.1. Let s0(0) = s0,0 and s1(0) = s1,0 be such that s
(0) = s0,0+s1,0+g
,
with g = O(); let s0, for T ∈ [0, T1], be the solution of (18) and let c0 be given by
(17). Let also s1 be the solution of
ds1
dT
= −(k + 1) [σ + 1− σc0(T )] s1(T ), T ∈ [0, T1]. (19)
Then there exists a constant C > 0 such that s(T ) = s0(T )+ω
(T ) with |ω| ≤ C.
Remark 2. Note that the solution of (18) lies in a compact set, [0, a], without
leaving it. Therefore, T1 = +∞.
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Proof. We first simplify equations (13) and (14) and write them as
ds
dT
= −(k + 1) [σ + 1− σc] s + kc (20)

dc
dT
= (k + 1) [(σ + 1− σc) s − c] (21)
We write c = c0, s
 = s0 + s1 + ω
 and insert these expressions in equation (20)
to obtain
ds0
dT
+ 
ds1
dT
+
dω
dT
= −(k + 1) [σ + 1− σc0] (s0 +  s1 + ω) + kc0 (22)
= −(k + 1) [σ + 1− σc0] s0 + kc0
−  (k + 1) [σ + 1− σc0] s1
− (k + 1) [σ + 1− σc0] ω (23)
and in equation (21) to obtain

dc0
dT
= (k + 1) [(σ + 1− σc0) s0 − c0] (24)
+  (k + 1) [σ + 1− σc0] s1
+ (k + 1) [σ + 1− σc0] ω
Now, taking into account (17)-(19), we deduce from (23)-(24) that ω is the
solution of
dω
dT
= −
(
ds0
dT
+
ds1
dT
)
(25)
ω(0) = g (26)
Since the right hand sides of (18) and (19) both satisfy Lipschitz conditions, and
g = O(), the conclusion follows.
4.2. Continuum of equilibria and stability. To solve numerically the system
of partial differential equations for the blood coagulation model, it is important
to impose good initial data, that could, for example, represent well mixed blood.
This can be considered by neglecting fluid velocity and the (very small) diffusion
coefficients. If we want to deal with more realistic situations, we could consider
medical data as well. In either case, as already referred (end of Sect. 3), a stability
analysis of the resulting system becomes mandatory. Neglecting fluid velocity and
diffusion coefficients leads to a system of ordinary differential equations and good
initial data should be an equilibrium solution to that system. (Remember that y
is an equilibrium solution to y′(t) = f(y(t)) if y′(t) = 0, that is, equilibria are the
zeros of f). In this case, the ODE system is as follows:
d[IXa]
dt =
k9 [XIa][IX]
K9M+[IX]
− h9 [IXa] [ATIII]
d[IX]
dt = −k9 [XIa][IX]K9M+[IX]
(27)

d[V IIIa]
dt =
k8 [IIa] [V III]
K8M+[V III]
− h8 [V IIIa]− hc8 [APC] [V IIIa]Hc8M+[V IIIa]
d[V III]
dt = −k8 [IIa] [V III]K8M+[V III]
(28)

d[Va]
dt =
k5 [IIa] [V ]
K5M+[V ]
− h5 [Va]− hc5 [APC] [Va]Hc5M+[Va]
d[V ]
dt = −k5 [IIa] [V ]K5M+[V ]
(29)
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
d[Xa]
dt =
k10 [Z] [X]
K10M+[X]
− h10 [Xa][ATIII]− hTFPI [TFPI][Xa]
d[X]
dt = − k10 [Z] [X]K10M+[X]
(30)

d[IIa]
dt =
k2 [W ] [II]
K2M+[II]
− h2 [IIa] [ATIII]
d[II]
dt = −k2 [W ] [II]K2M+[II]
(31)

d[Ia]
dt =
k1 [IIa] [I]
K1M+[I]
− h1 [PLA] [Ia]H1M+[Ia]
d[I]
dt = −k1 [IIa] [I]K1M+[I]
(32)

d[XIa]
dt =
k11 [IIa] [XI]
K11M+[XI]
− hA311 [XIa][ATIII]− hL111 [XIa][L1AT ]
d[XI]
dt = −k11 [IIa] [XI]K11M+[XI]
(33)
{
d[ATIII]
dt
= − (h9[IXa] + h10[Xa] + h2[IIa] + hA311 [XIa]) [ATIII] (34){
d[TFPI]
dt
= −hTFPI [TFPI][Xa] (35)
d[APC]
dt =
kPC [IIa] [PC]
KPCM+[PC]
− hPC [APC][L1AT ]
d[PC]
dt = −kPC [IIa] [PC]KPCM+[PC]
(36)
{
d[L1AT ]
dt
= −hPC [APC][L1AT ]− hL111 [XIa][L1AT ] (37){
d[tPA]
dt
= 0 (38)

d[PLA]
dt =
kPLA [tPA] [PLS]
KPLAM+[PLS]
−hPLA[PLA][L2AP ]
d[PLS]
dt = −kPLA [tPA] [PLS]KPLAM+[PLS]
(39)
{
d[L2AP ]
dt
= −hPLA[PLA][L2AP ] (40)
Equilibria for this system are the solutions to the following equations:
[XIa] [IX] = 0,
[IIa] [V III] = 0,
[IIa] [V ] = 0,
[Z] [X] = 0,
[Xa] [TFPI] = 0,
[IXa] [ATIII] = 0,
[V IIIa] = 0,
[V a] = 0,
[Xa] [ATIII] = 0,
[W ] [II] = 0,
(41)
[IIa] [ATIII] = 0,
[PLA] [Ia] = 0,
[XIa] [ATIII] = 0,
[IIa] [PC] = 0,
[tPA] [PLS] = 0,
[IIa] [I] = 0,
[IIa] [XI] = 0,
[XIa] [L1AT ] = 0,
[APC] [L1AT ] = 0,
[PLA] [L2AP ] = 0.
(42)
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By solving system (41)-(42) we are able to show that system (27)-(40) has a
continuum of equilibrium points. This is a feature, common to several non nega-
tive dynamical systems, that complicates its stability analysis and, in these cases,
semistability has to be called for.
The zero solution is an obvious equilibrium solution. But there are many other
configurations of equilibria. Moreover, if we solve the system above we find that
there are non isolated equilibria. Continuum of equilibria are common to nonnega-
tive dynamical systems as well as to compartmental dynamical systems. The blood
coagulation system, modeling a cascade of biochemical reactions, is an example of
a nonnegative compartmental system. For a continuum of equilibria, asymptotic
stability must be ruled out since in every neighborhood of an equilibrium point
there exists a different one. In this case, the concept of semistability should be
used. Semistability was introduced for the first time in [7] and requires that solu-
tion curves converge to limit points that are Lyapunov stable. Since semistability
is much less known than classical stability, we briefly recall its main definitions and
results, following [4].
Let
y′(t) = f(y(t)), (43)
where f : D :→ Rn is continuous on the open set D ⊂ Rn.
Definition 4.2. Given x ∈ D, the orbit Ox of x is the set {ψ(t, x) : t ≥ 0}, where
ψ(t, x) is the solution of (43) starting from the initial condition y(0) = x.
Definition 4.3. A set G is positively invariant (under f) if ψ(t, x) ∈ G, for all
x ∈ G and t ≥ 0.
Let G ⊂ D be a locally compact, positively invariant set such that Ox ⊂ G, for
all x ∈ G.
Definition 4.4. A set U ⊂ G is relatively bounded in G if U is a compact subset
of G.
The following is a definition of derivative along a solution of (43):
Definition 4.5. Given V : G :→ Rn,
V˙ (x) = lim
t→0+
1
t
{V (ψ(t, x))− V (x)} .
Definition 4.6. A function U : G → R is proper if U−1(K) is a compact set in G,
for all compact K ⊂ R.
Proposition 1. If there exists a continuous, proper function U : G :→ R such that
U˙ is defined on G, U ≥ 0 and U˙(x) ≤ 0, for all x ∈ G, then Ox is relatively bounded
on G, for every x ∈ G.
For a given K ⊂ Rn, we denote by coco(K) the cone generated by the union of
the convex hulls of the connected components of K.
Definition 4.7. The direction cone Fx of f at x, relatively to G, is the intersection
of all sets coco(f(U)\ {0}), where U ⊂ G is an open neighborhood of x in G.
A generalization of a tangent space is provided by the tangent cone. Let x ∈
K ⊂ Rn.
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Definition 4.8. (i) A vector v ∈ Rn is tangent to K, at x, if there exists a sequence
{xi} ⊂ K and a sequence hi → 0 such that
lim
t→+∞
1
hi
(xi − x) = v.
(ii) The tangent cone to K at x is the closed cone, TxK, of all vectors tangent
to K at x.
This implies that the vector field f is nontangent to K ⊂ G, at x ∈ K, if
TxK ∩ Fx ⊂ {0}.
Direction cones are not easy to determine in applications. Instead, we make
use of the limiting direction set of f . First, let E be the set of equilibria of (43).
For x ∈ G\E , a vector v ∈ Sn−1 is a limiting direction of f at x if there exists
{xi} ⊂ G\E such that lim
i→∞
xi = x and lim
i→∞
1
‖f(xi)‖f(xi) = v.
Definition 4.9. For x ∈ G, the positive set of x relative to G, O∞x , is the set
of points z ∈ G such that there exists a divergent sequence {ti} ⊂ [0, ∞) with
lim
i→∞
ψ(ti, x) = z.
Proposition 2. Let x ∈ G. If Ox is relatively bounded in G, then O∞x is nonempty,
compact, invariant, connected and ψ(t, x) → O∞x , as t → ∞; that is, for every
open subset U ⊂ G that contains O∞x , there exists T > 0 such that ψ(t, x) ∈ U for
all t > T . Moreover, lim
t→∞
ψ(t, x) exists and is contained in G if and only if O∞x
contains exactly one point.
Proposition 3. Let x ∈ G and suppose that O∞x is nonempty. Then, lim
t→∞
ψ(t, x)
exists and is contained in G if and only if there exists z ∈ O∞x such that f is
nontangent to O∞x at z, relative to G.
Proposition 4. Suppose V : G :→ R is a continuous function such that V˙ is
defined on G and V˙ (x) ≤ 0, for all x ∈ G. Let x ∈ G be such that Ox is rela-
tively bounded in G. Let P and N denote the largest invariant subsets of the sets
{z ∈ G : V (z) ≤ V (x)} and V˙ −1(0), respectively. Then O∞x ⊂ P ∩ N . In addition,
if V˙ ≡ 0, then O∞x is contained in the largest invariant subset of V −1(V (x)).
Definition 4.10. An equilibrium point x ∈ G is semistable, relative to G, if there
exists an open neighborhood U ⊂ G, of x, such that if z ∈ U then limt→∞ψ(t, z)
exists and is Lyapunov stable.
Proposition 5. Suppose V : G :→ R is a continuous function such that V˙ is defined
on G. Let x ∈ E be a local maximizer of V˙ relative to G and a local minimizer of V
relative to the set K ≡ G\V˙ −1(0). Let W ⊂ G be an open neighborhood of x. For
every z ∈ E ∩W, let Mz denote the largest connected subset of V −1(V (z))∩W that
is negatively invariant and contains z. Let N denote the largest negatively invariant
subset of V˙ −1(0)∩W and, for every z ∈ N , let Nz denote the connected component
of N containing z.
If there exists an open neighborhood U ⊂ W of x such that every equilibrium in
U is a local minimizer of V relative to K and, for every z ∈ N ∩U , f is nontangent
to Nz at z relative to G, then x is semistable relative to G.
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4.3. Semistability of a simplified biochemical model. We now show how one
can prove semistability of equilibria. However, instead of considering the full co-
agulation system (27)-(40), we take a simplified one which deals with a small, but
significant part of the coagulation cascade. In fact, we consider a system consisting
of equations (31), (32), (39) and (40), slightly modified. A similar system has been
considered in [6]. Although it does not include all blood species involved in the
coagulation cascade, it still has the ability to model coagulation and lysis as well:
d[IIa]
dt
=
k2 [W ] [II]
K2M + [II]
(44)
d[II]
dt
= − k2 [W ] [II]
K2M + [II]
(45)
d[Ia]
dt
=
k1 [IIa] [I]
K1M + [I]
− h1 [PLA] [Ia]
H1M + [Ia]
(46)
d[I]
dt
= −k1 [IIa] [I]
K1M + [I]
(47)
d[PLA]
dt
=
kPLA [tPA] [PLS]
KPLAM + [PLS]
−hPLA[PLA][L2AP ] (48)
d[PLS]
dt
= −kPLA [tPA] [PLS]
KPLAM + [PLS]
(49)
d[L2AP ]
dt
= −hPLA[PLA][L2AP ] (50)
Like in [6], we also suppose that Prothrombinase concentration, [W ], is a given
function of time only. For closing, we have neglected the action of Antithrombin-3
in equation (44). Besides Prothrombinase, the system involves Prothrombin, II,
Thrombin, IIa, Fibrinogen, I, Fibrin, Ia, Plasminogen, PLS, Plasmin, PLA, α2-
Antiplasmin, L2AP , and Tissue Plasminogen Activator, tPA (see Table 1). Note,
however, that the first four equations are coupled with the last three equations
through Plasmin concentration, [PLA], only. With this in mind we will further
simplify, by assuming that [PLA] is a given function of time and consider the first
four equations only.
Let y = (y1, y2, y3, y4) ≡ ([IIa], [Ia], [II], [I])T . Then equations (44)-(47) can be
written, in form (43), as
dy
dt
= f(y) ≡ v1y1y4 + v2y2 + v3y3 (51)
with
v1 =

0
k1
(K1M+[I])
0
−k1
(K1M+[I])
 ; v2 =

0
−h1[PLA]
(H1M+[Ia])
0
0
 ; v3 =

k2[W ]
(K2M+[II])
0
−k2[W ]
(K2M+[II])
0
 .
Let now G = {x ∈ R4 : xi ≥ 0}. Note that set G is positively invariant, under
the action of the vector field defined by (51).
Since vectors vi, i = 1, 2, 3 are linearly independent, equilibria are the solutions
to
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 y1 y4 = 0,y2 = 0,
y3 = 0.
so that the set E , of equilibria, is E = E1 ∪ E2 with
E1 = {y ∈ G : y2 = y3 = y4 = 0} ,
E2 = {y ∈ G : y1 = y2 = y3 = 0} .
In view of the definitions and results outlined in Sect. 4.2 (see also [4]) we
conclude that f is nontangent to E1, in every point x ∈ E1. In fact, the direction
cone Fx of f at any x ∈ G is contained in the span of {vi}i=1,··· ,3. On the other
hand, given x ∈ E1, every vector tangent to E1, at x, is contained in the span of
v4 = [1 0 0 0]
T . Since
span {v1, v2, v3} ∩ span {v4} = {0} , (52)
then the tangent cone Tx satisfies TxE1 ∩ Fx ⊂ {0}, for all x ∈ E1. Thus f is
nontangent to E1, in every point x ∈ E1.
Now, we claim that every equilibrium point x ∈ E1 is semistable. For that
we consider the following (Lyapunov candidate) function V : G → R defined by
V (x) = x2 + x3 + x4. We can see that V (x) ≥ 0, for all x ∈ G and V −1(0) = E1
and, consequently, every point in E1 is a local minimizer of V , relative to G. On the
other hand,
V˙ (x) = −h1[PLA]x2
H1M + x2
− k2Wx3
K2M + x3
.
Therefore V˙ (x) ≤ 0, for all x ∈ G,
V˙ −1(0) = {x ∈ G : x2 = 0, x3 = 0}
and the largest negatively invariant subset of V˙ −1(0) contains E .
Let x ∈ E1. There exists a relatively open neighborhood U ⊂ G such that
U ∩ E1 = U ∩ E . It follows that every z ∈ U ∩ E is a local maximizer of V˙ and a
local minimizer of V , relative to G. Since f is nontangent to E at every z ∈ U ∩ E ,
it follows, from Proposition 5, after taking W = G, that every equilibrium in E1 is
semistable, relative to G.
Remark 3. It is not possible to show semistability of equilibria for E2, using the
previous approach. Hence, and to study equilibria of the complete system (27)-(40),
a different technique should be used, for example constructing Lyapunov functions.
This is the object of current research.
5. Concluding remarks. A mathematical model of coagulation and fibrinolysis in
flowing blood that integrates biochemical, physiologic and rheological factors, based
on a more complex model developed in [1], has been considered in this work. Three-
dimensional numerical simulations have been performed in an idealized stenosed
blood vessel, following first simulations of the same model detailed in [5].
Preliminary results on the stability analysis of the system of equations associated
to the biochemical part of the previous model, simulating the cascade of enzymatic
reactions involved in the formation, growth and lysis of clots in quiescent plasma,
have also been obtained. In particular, using a nontangency-based Lyapunov cri-
terion, we have shown semistability for the kinetics of some of the most relevant
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Michaelis-Menten chemical reactions involved in the model, that have a continuum
of equilibria. Equilibria studied here are non clotting, due to the fact that they
represent (final) configurations where Fibrin is absent (see, for example, [12] for a
similar situation).
Several additional constituents and their interactions involved in platelet acti-
vation and aggregation, such as von-Willebrand Factor (vWF) and others, can be
incorporated to develop new models that capture more realistic features. We be-
lieve that a deep analysis of stability results for these systems can be used to gain
a better understanding of hemostasis and its regulation.
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